JAMIE GARONZIK: Open Payments
NPI 1710422688 · ELLICOTT CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 42 payments from 18 companies in 2025. Trend: 2023 $442 · 2024 $995 · 2025 $950
Food & beverage: $950
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $180 |
| Novartis Pharmaceuticals Corporation | 4 | $103 |
| Novo Nordisk Inc | 5 | $100 |
| PFIZER INC. | 3 | $66 |
| Amgen Inc. | 3 | $54 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Dexcom, Inc. | 2 | $52 |
| Abbott Laboratories | 2 | $47 |
| Inspire Medical Systems, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
Products named: MOUNJARO, LEQVIO, EVENITY, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, INSPIRE, ELIQUIS, XYOSTED.
Industry payments across MD — which companies pay providers there.
